Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
NeurogesX Inc (NGSX)
|
Add to portfolio |
|
|
|
| Price: |
$2.06
| | Metrics |
| OS: |
33.3
|
M
| |
|
|
| Market cap: |
$68.7
|
M
| |
|
|
|
Net debt:
|
$47.2
|
M
| |
|
|
|
EV:
|
$116
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($18.0)
|
M
| |
|
|
|
EBIT
|
($18.4)
|
M
| |
|
|
| EPS |
($1.08)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 | Dec-31-05 |
| Revenues | 11.5 | 8.3 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue growth | 39.2% | 312.1% | | | | | |
| Cost of goods sold | 0.7 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 10.8 | 7.7 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross margin | 94.0% | 93.5% | 100.0% | | | | |
| Selling, general and administrative | 36.4 | 36.4 | 12.4 | 10.2 | 7.5 | | |
| Research and development | 13.6 | 11.2 | 11.2 | 16.1 | 25.3 | 20.9 | 11.8 |
| General and administrative | | | | | | 6.1 | 1.7 |
| EBIT | -39.2 | -39.8 | -21.6 | -26.3 | -32.8 | -27.0 | -13.6 |
| EBIT margin | -340.4% | -481.6% | -1079.2% | | | | |
| Pre-tax income | -49.5 | -44.5 | -21.9 | -26.0 | -36.6 | -30.1 | -13.1 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | -4.6 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 12.6% | 0.0% | |
| Net income | -49.5 | -44.5 | -21.9 | -26.0 | -36.6 | -41.4 | -13.1 |
| Net margin | -430.7% | -538.5% | -1090.1% | | | | |
| |
| Diluted EPS | ($2.15) | ($2.51) | ($1.24) | ($1.49) | ($4.06) | ($116.20) | $0.00 |
| Shares outstanding (diluted) | 23.0 | 17.8 | 17.6 | 17.5 | 9.0 | 0.4 | 0.2 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|